Mouse hepatitis virus nucleocapsid protein as a translational effector of viral mRNAs

Advances in Experimental Medicine and Biology

Volumn 440, Issue , 1998, Pages 313-318

  Tahara, Stanley M ^b   Dietlin, Therese A ^a   Nelson, Gary W ^a   Stohlman, Stephen A ^b   Manno, David J ^a  

^a Department of Molecular Microbiology and Immunology ^*

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VIRUS RNA;

ARTICLE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; RNA TRANSLATION; SEQUENCE ANALYSIS; VIRUS TRANSCRIPTION;

CORONAVIRUS; FELIS CATUS; MURINAE; MURINE HEPATITIS VIRUS; RNA VIRUSES;

EID: 0031753101     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5331-1_41     Document Type: Article

References (16)

1. Bradford, M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of dye binding, Anal. Biochem. 72:248-254.
2. Cullen, B., and Malim, M. H., 1992, Secreted placental alkaline phosphatase as a eukaryotic reporter gene, Meth. Enzymol. 216:362-368.
3. Gorman, C. M., Moffat, L. F., and Howard, B. H., 1982, Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells, Molec. Cell. Biol. 2:1044-1051.
4. Hilton, A., Mizzen, L., Macintyre, G., Cheley, S., and Anderson, R., 1986, Translational control in murine hepatitis virus infection, J. Gen. Virol. 67:923-932.
5. Kyuwa, S., Cohen, M., Nelson, G., Tahara, S. M., and Stohlman, S. A., 1994, Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis, J. Virol. 68:6815-6819.
6. Lin, A. Y., Chang, S. C., and Lee, A. S., 1986, A calcium ionophore-inducible cellular promoter is highly active and has enhancerlike properties, Molec. Cell Biol. 6:1235-1243.
7. Nelson, G. W., 1996, [Ph.D. Dissertation]. (University of Southern California, Los Angeles, CA).
8. Nelson, G. W., and Stohlman, S. A., 1993, Localization of the RNA-binding domain of mouse hepatitis virus nucleocapsid protein, J. Gen. Virol. 74:1975-1979.
9. Sanger, F., Nicklen, S., and Coulson, A. R., 1977, DNA sequencing with chain-terminating inhibitors, Proc. Natl. Acad. Sci. USA 74:5463-5467.
10. Schneider, R., and Shenk, T., 1987, Impact of virus infection on host cell protein synthesis, Annu. Rev. Biochem. 56:317-332.
11. Siddell, S., Wege, H., Barthel, A., and ter Meulen, V., 1981, Intracellular protein synthesis and the in vitro translation of coronavirus JHM mRNA, Adv. Exptl. Biol. Med. 142:193-207.
12. Southern, P. J., and Berg, P., 1982, Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter, J. Mol. Appl. Gen. 1:327-341.
13. Stohlman, S. A., Baric, R. S., Nelson, G. N., Soe, L. H., Welter, L. M., and Deans, R. J., 1988, Specific interaction between coronavirus leader RNA and nucleocapsid protein, J. Virol. 62:4288-4295.
14. Tahara, S. M., Dietlin, T. A., Bergmann, C. C., Nelson, G. W., Kyuwa, S., Anthony, R. P., and Stohlman, S. A., 1994, Coronavirus translational regulation: leader affects mRNA efficiency, Virology 202:621-630.
15. van Marie, G., Luytjes, W., van der Most, R. G., van der Straaten, T., and Spaan, W. J. M., 1995, Regulation of coronavirus mRNA transcription, J. Virol. 69:7851-7856.
16. Zhang, X., Liao, C.-L., and Lai, M. M.-C., 1994, Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis, J. Virol. 68:4738-4746.